PRESSTV — broadcast
20260920 073000 UTC
340 transcript segments
Google Cloud Speech-to-Text API (Chirp) + Gemini 2.5 Flash Non-Thinking
Data courtesy of The GDELT Project (https://www.gdeltproject.org/), from the Internet Archive TV News Archive.
Machine transcription. Treat it as a searchable index of what was broadcast, not a verbatim quotation record.

[00:00:00] to reach deep inside Saudi Arabia. In
[00:00:03] September 2019, its drone strike on the ABC and
[00:00:07] Kurais oil facilities exposed the vulnerability of Saudi
[00:00:11] Aramco despite billions of dollars worth of American-made air
[00:00:14] defense systems. Now the resistance movement warns
[00:00:18] that any new attack on Yemen's infrastructure could bring
[00:00:21] even more strategic targets into range, including the vital
[00:00:25] oil facilities at Yanbu.
[00:00:27] Today, more than 70% of Saudi oil. exports bypass
[00:00:31] the straight of Hormus through pipelines to Yanbu on the Red
[00:00:34] Sea, but from there they must still pass through the Bob Al
[00:00:38] Mandab straight. If that route is closed, Saudi
[00:00:41] Arabia's alternative export corridor disappears.
[00:00:45] Ansarula has already shown it can disrupt one of the world's busiest
[00:00:48] maritime choke points. Since the outbreak of the Gaza War in
[00:00:52] 2023, it is launch attacks in the Red Sea,
[00:00:55] declaring that it would target vessels linked to Israel in support of the Palestini.
[00:01:01] The Red Sea operations have forced major shipping companies to re-root
[00:01:05] around Southern Africa, increased global transport costs
[00:01:08] and pushed Israel's southern port of ilot, the brink of
[00:01:12] collapse. If both the Straight of Hormus and Bob
[00:01:16] Almandab were closed at the same time. Nearly a quarter of the
[00:01:19] world's oil and gas supply and almost one third of global container
[00:01:23] traffic could be affected. Oil prices could sore toward
[00:01:27] $200 per barrel while Europe's energy. Security would face
[00:01:30] severe pressure.
[00:01:33] For Ansarula, Yemen is not merely another battlefield, it
[00:01:36] is a strategic front with the power to reshape the global
[00:01:40] economy.
[00:01:42] The axis of resistance still holds powerful strategic cards in
[00:01:46] reserve. Cards that once played, could leave
[00:01:50] even America unable to respond despite all its military
[00:01:53] might.
[00:02:04] My name is Marjon, I was 18 years old when I
[00:02:08] emigrated from Iran, but not to Turkey and
[00:02:11] then to Germany, which was common those days. I
[00:02:15] went 1200 km away to a place
[00:02:18] where you understand the real meaning of Jedlag once
[00:02:22] you arrived there. After a while, I realized
[00:02:25] Jitlack is the easiest part of
[00:02:28] immigration.
[00:02:32] When few years passed, I settled
[00:02:35] in, although no place can be like homeland
[00:02:38] for an immigrant, but I was finally able to see the
[00:02:42] good things about living in the US, there I
[00:02:45] got a job in a pharmacy on the coast in Georgia.
[00:02:49] I was mostly focused on my own stuff, but my close friend
[00:02:53] Judy didn't see life that way. She was
[00:02:56] originally from India, she was considered a... second
[00:03:00] generation immigrant and regarded herself
[00:03:03] completely American.
[00:03:07] That's what led her to get mostly involved in
[00:03:11] charitable work focused on social traumas. Judy
[00:03:15] had chosen a specific field that receives little
[00:03:18] attention in the world, and it
[00:03:20] deals with what happens after the trauma. When a drug
[00:03:24] addict quits taking drugs, his need for
[00:03:27] support increases. For example, If he doesn't
[00:03:31] find a job after quitting taking drugs, or if
[00:03:34] he's not accepted by the society, he will soon
[00:03:37] return to his previous
[00:03:39] community.
[00:03:44] There is a proverb that says it's not important to
[00:03:47] make friends, but it's difficult to keep them. When it
[00:03:51] comes to quitting taking drugs, this may be
[00:03:55] very decisive. Judy expanded her activity in
[00:03:58] 2021. She launched a magazine and started
[00:04:02] writing reports about countries or non-governmental
[00:04:05] organizations from around the world to show what
[00:04:09] ideas they use for people who have quited taking
[00:04:12] drugs. In each country she assigned this task to
[00:04:15] somebody. A middle east section was supposed to be there as
[00:04:19] well, but she had no reporter there and she was looking
[00:04:22] for somebody active in the field.
[00:04:26] I've been back to Iran for around three months now.
[00:04:30] and I'd like to be there for my mom and dad during the years when they
[00:04:33] need more help. During the days I was thinking and looking for
[00:04:37] a job, I remember Judy and her work. I
[00:04:41] figured it would be a good idea to call her and take over the section
[00:04:45] related to Iran. Yeah, it's been it's been about a
[00:04:48] couple of months I've been back. My parents are getting
[00:04:51] older so I got to be around taking care of them, so yeah, I've been
[00:04:55] back. Yeah, yeah, no, um, I haven't
[00:04:59] found the job. yet, I'm in the market for a job,
[00:05:03] it's it's gonna take a little, um, I'm trying to find
[00:05:05] myself, um, I'm trying to find myself here
[00:05:11] They put their fingers in their ears now, uh-huh.
[00:05:14] um, it's let me look into it, um, so it's
[00:05:17] especially it's in the realm of journalism, um, I definitely
[00:05:20] want it, I started searching on the
[00:05:23] internet, I found some NGOs and factories that
[00:05:27] worked on it, there was a tomato paste factory in
[00:05:30] Mashad which chose its workers from among people with
[00:05:34] criminal records, I also found addiction treatment, also
[00:05:38] found addiction treatment center in the north of the
[00:05:41] country. which trained people who were interesting one was
[00:05:45] the knowledge-based company that helped addicts quit drugs
[00:05:48] and employed them for few months. knowledge-based
[00:05:52] company with a medical focus is the strangest place for
[00:05:56] such a thing. the idea would definitely surprise Judy.
[00:07:22] he came to us and offered us, saying that you have production, you have a production process,
[00:07:25] you have workers,
[00:07:27] come,
[00:07:30] enter the field of social responsibility. Now that, for example, your sales trend
[00:07:34] has improved a little, let's bring the production discussion
[00:07:38] into a group
[00:07:41] that now these people who have quit, some time has passed
[00:07:45] since their quitting, so that they can return to society,
[00:07:48] they need to go through a transitional process,
[00:07:52] and in this transition they are going through, a process, for example, now the existing
[00:07:56] laws dictate a process of at least 4 months to
[00:07:59] a maximum of 8 months to stay with us, and
[00:08:03] we, as human resources who
[00:08:07] want to have our production discussion, we should use them. Firstly,
[00:08:11] because of the disease they had, they did not have
[00:08:14] and do not have the ability to work full-time. Secondly,
[00:08:17] these were our problems. The second problem
[00:08:20] was that
[00:08:23] after 4 months or a maximum of 8 months,
[00:08:27] they have to leave us,
[00:08:30] meaning they have to return to society.
[00:08:33] Naturally, whatever we want to do, we have a training
[00:08:37] process. You have to be trained, no matter how simple
[00:08:40] the device is.
[00:09:13] It's called uh Behrad Ruesh Royan um it
[00:09:17] produces um catheters to transfer embryos
[00:09:20] and um it's it's as we spoke
[00:09:24] about it it's a knowledge based company
[00:09:27] and um they worked from you on uh
[00:09:31] what do you
[00:09:32] think
[00:09:37] okay all right okay all
[00:09:41] right oh
[00:10:13] the issue to me to a large extent, wanted to
[00:10:16] see that space up close, luckily for
[00:10:19] me, arrived at
[00:10:21] lunchtime,
[00:11:55] It works. You see, the way this product
[00:11:58] is used is that when a two or three-day-old embryo
[00:12:02] has been created in the lab using the in vitro
[00:12:06] fertilization method, it is loaded into this
[00:12:09] tube, which we call the inner, and then
[00:12:12] the gynecologist places
[00:12:16] the outer into the
[00:12:20] path that leads to the uterus, and
[00:12:23] the doctor inserts
[00:12:26] it into the uterus through this path, which is now open as a
[00:12:30] guide. The embryo is inserted into
[00:12:33] the uterus. At the same time, the doctor is monitoring it with
[00:12:37] ultrasound. One of the features of this product is that it must be visible on the
[00:12:40] ultrasound. Yes, the ultrasound
[00:12:44] is being monitored. On this side, the product itself has some
[00:12:48] indicators that, based on these indicators,
[00:12:51] are aligned with, for example, the alignment.
[00:12:55] These two pieces, in the appropriate place as determined by them,
[00:12:58] insert the embryo into
[00:13:01] the uterus, and then they pull them out together. It's a very
[00:13:05] precise and very delicate job. One aspect of it is
[00:13:09] the delicacy of this process, which good
[00:13:12] specialists do. Another aspect is that there is a mother on the other side who might
[00:13:15] only have two embryos, and if these two
[00:13:19] transfers don't happen correctly and she doesn't get pregnant,
[00:13:22] she might never have a child again.
[00:13:33] and what exactly it is used for, but by a simple
[00:13:37] search, i found many schematic videos which
[00:13:40] explained the issue well, in order for an embryo to be
[00:13:44] created, an egg must be released from the
[00:13:47] ovary and it should be bombarded in the uterus with a large number
[00:13:51] of sperms.
[00:13:58] This is when a single cell embryo is formed, then
[00:14:02] the fetus or the multi-cell embryo must be transferred to
[00:14:06] the uterus. This important transfer, which means
[00:14:09] all previous efforts have come to fruition is carried
[00:14:13] out by an embryo transfer catheter, but this
[00:14:17] company wasn't an ordinary company, when it the
[00:14:20] production story can cert, the production story can certainly
[00:14:24] be inter'.
[00:14:55] This is born, if there is a mistake anywhere in the
[00:14:58] work, what are we responsible for? What do we want to do with its responsibility?
[00:15:02] He came to work with this doubt and hesitation and said, "Well, I
[00:15:06] can't. I'm not continuing." Meaning, we told him, "Come on, let's do this together." He said,
[00:15:09] "No, I won't get involved in this product." Well, I had seen around me people
[00:15:13] who had infertility
[00:15:17] problems, for example, and how important this issue was for them. It became
[00:15:21] interesting for me to start this product and so on.
[00:15:25] So I followed up. I started following up and came forward, forward,
[00:15:28] forward. At some point, we concluded that, yes, this can be produced
[00:15:32] in Iran. So from then, almost in December
[00:15:35] 2019, we started
[00:15:39] the executive work and started the work. We were involved for almost 6-7 months
[00:15:42] to reach a sample that we could actually take
[00:15:46] and give. For example, we had reached a prototype, but we were so
[00:15:50] scared to go and give it to a doctor to test it and see
[00:15:53] if we could get a response
[00:15:57] from it or not. For example, the first place, now Dr.
[00:16:01] Product himself, since he was from Mashhad, said, "I'll take it to
[00:16:04] Mashhad. Tehran is a bit risky."
[00:17:07] I make it, for example, I come and shave it or for example, I sand it.
[00:17:11] The surface, when you cut it, the edge of the cut has a sharpness.
[00:17:14] How do I remove that sharpness? Before that, we came and said, "Well, maybe
[00:17:17] we should melt it with a method, for example." For example, we came and
[00:17:21] tested the solvents that found this hose, and we saw that it's not what
[00:17:24] we want and what its American sample has, it doesn't give that
[00:17:28] quality. It's not possible.
[00:17:31] It took us a month or so. I myself said, "Well, tip forming,
[00:17:35] let's see, they have worked so much. For example, let's
[00:17:37] go to them, we'll get their machine." After all,
[00:17:41] we'll open the machine and figure out what's what. We went to
[00:17:44] one of the experts in this field of tip forming in
[00:17:48] Iran. At that time, I myself was earning 2.5 million
[00:17:52] salaries per month. They were earning 2-2.5 salaries. They told me to pay
[00:17:56] 60 million Tomans. We will
[00:17:59] build their machine, but it will take three months because it has
[00:18:02] R&D, and there's no guarantee that we will reach
[00:18:06] an output. So I said, "Well, why should you use 60 million?
[00:18:10] I'll do
[00:18:13] it myself." And I will do this work myself, but the truth is that we
[00:18:16] reached a new technology in tip forming.
[00:18:20] That is, the tip forming of the embryo transfer
[00:18:23] catheter is with a method that is very
[00:18:26] low-cost and can be produced in high numbers. Now
[00:18:30] our daily production is much higher than the standards that exist
[00:18:34] in the world for tip forming and shaping. Why? Because we
[00:20:37] In this section that you see, in this
[00:20:41] section, in fact,
[00:20:44] the parts that we have are checked,
[00:20:47] packaged, and now sewn. Now, we usually don't
[00:20:51] cover the machines to make their maintenance easy,
[00:20:55] because the machines are our own, so there's no need
[00:20:58] that you built them. Yes, they are our own make.
[00:21:02] You said that you built these machines yourselves. There are 10-12 machines
[00:21:05] that are now doing this production work themselves. Why
[00:21:09] did you make these machines yourselves? You could have imported them.
[00:21:13] You are producing a product that this product
[00:21:16] is unique not only in Iran
[00:21:20] but also in the world.
[00:21:22] And naturally, its machines are also unique.
[00:21:26] And its machines are not available everywhere and everyone
[00:21:30] produces them. The number of companies that are producing this product
[00:21:33] is less than the number of fingers on one hand. Perhaps it's even less than the fingers on one hand.
[00:21:37] So naturally, there is a technology in that machine
[00:21:40] that those who built this machine
[00:21:44] firstly don't sell it, and secondly,
[00:21:47] there must be differences between similar machines.
[00:21:52] that those don't have. For this reason, we designed all the machines that were
[00:21:56] for the production line ourselves.
[00:21:59] We built them according to our needs.
[00:22:02] What I am seeing is two tubes, which
[00:22:06] in my opinion, is a lot,
[00:22:09] but I know that technologically it has had its
[00:22:12] own challenges for you.
[00:22:16] Anyone who sees our product, now.
[00:22:20] In terms of appearing to be a simple product,
[00:22:23] but if I want to say why the product
[00:22:26] is considered a technological product,
[00:22:29] I just need to say that, for example, the countries that produce
[00:22:32] this product are considered the owners of the technology in
[00:22:36] the world, like America, like, for example,
[00:22:40] France, Japan, and on this
[00:22:43] side, only, for example, two or three brands have
[00:22:46] quality approval in Iran. That is, many
[00:22:50] doctors are not willing to, for example, use a Japanese embryo
[00:22:53] transfer catheter at all. For example, or
[00:22:56] Chinese. There are two or three Chinese brands. I don't think
[00:23:00] even one has been able to lower it. I didn't want to say the price is
[00:23:04] lower. I didn't want to say the problem was the price or not. No, in this product,
[00:23:08] you see, because you are dealing with people's hopes
[00:23:12] here, that's why the price
[00:23:15] of this product is very
[00:23:18] important.
[00:23:50] product that helps giving birth to babies is a
[00:23:53] great achievement. i think helping people who have been
[00:23:56] struggling with addiction for years to be born again is
[00:24:00] a greater success. this is
[00:24:03] what distinguishes this company from the rest of its
[00:24:06] competitors. maybe this company can be a good
[00:24:09] model to help the addicts return to
[00:24:12] society. hope Jud's audiences can
[00:24:15] replicate this idea in other countries
[00:24:18] too.
[00:24:24] My name is Kamran. I am an addict who has been clean for 7 months and 15 days.
[00:24:49] an addict for 9 years.
[00:25:08] for anyone seeking to defend themselves from cyber
[00:25:11] attack,
[00:25:13] we are being controld from
[00:25:16] above.
[00:25:50] Do we have any other weapon against this crime against humanity?
[00:25:53] Blind killing.
[00:25:55] You see.
[00:26:01] from the thunder.
[00:26:15] On June 13th, 2025, war came to Dr. Ali Fuladman's
[00:26:19] home and Israely strike killed his wife and left the Iranian scientist
[00:26:23] seriously wounded. It was not the last attempt on his life. Less than
[00:26:27] year later, during the 2026 war, Fuladvan
[00:26:30] was targeted again this time. He was martered. Fuladman was not
[00:26:34] a politician, he was not a military commander. He was
[00:26:38] scientist, a senior researcher who spent
[00:26:41] years working on strategic technologies and on
[00:26:44] strategic technologies and
[00:26:47] he served at Iran's organization of defensive innovation and research
[00:26:51] known as SPND, eventually becoming his head
[00:26:54] of research. His work had already made him a target of
[00:26:57] American pressure. On October 1st, 2025, the U.S. Treasury
[00:27:01] Department sanctioned him, but fulad van's most important
[00:27:05] contribution could never be captured in a sanction
[00:27:08] list or an official title.
[00:27:11] he taught, he trained young researchers, shared what he had
[00:27:15] learned and helped prepare new generation to work in some
[00:27:19] of Iran's most advanced fields of science and technology. for him,
[00:27:22] scientific power was not simply about what one scientist
[00:27:26] could achieve, it was about what could be passed on from one
[00:27:29] generation to the next, and what may explain, why scientists
[00:27:33] like Fuladvan can become targets? eliminating
[00:27:37] scientistts may silence one voice, but it cannot erase the knowledge of
[00:27:41] that voice has already passed to others. just days after his
[00:27:44] martterdom, the prestigious journal science in its April 6th,
[00:27:47] 2026 issue reported on the growing Israeli campaign targeting
[00:27:51] Iranian scientists and universities. full advanced
[00:27:54] death had become part of a larger story, a war in
[00:27:58] which those capable of advancing iran
[00:28:00] scientific and technolo logical future were
[00:28:03] themselves being targeted, but there is limit to what an
[00:28:07] attack can destroy a laboratory can be hit a
[00:28:10] researcher can be killed, a generation can lose one of its
[00:28:14] teachers, but knowledge survives. it is carried by the
[00:28:17] students, they trained, the researchers they inspired, and the
[00:28:21] people who continue the work after they are gone. that was
[00:28:24] full advance other legacy, one no missile could
[00:28:27] eliminate.
[00:30:07] Headlines on Press TV: Iran stop security officials says the
[00:30:11] only way for the US to get out of the predicament it has created
[00:30:15] is to accept Iran's seven
[00:30:17] conditions.
[00:30:20] Yemen wants Saudi Arabia that any escalation against the country
[00:30:24] will be met with stronger response and increases the price that
[00:30:28] Riad has to
[00:30:29] pay.
[00:30:32] And four people have been killed in a US strike on an alleged drug
[00:30:36] trafficking boat in the
[00:30:37] Caribbean.